Developer docs
API playgroundTry for free, no card

Search company profiles

Brain Sentinel

Full company profile

uuid000afuo

Namestring
Brain Sentinel
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Brain Sentinel is a privately held, early-stage medical device company founded in 2011 and headquartered in San Antonio, Texas. The company develops AI-driven wearable technology aimed at detecting and predicting convulsive seizures in patients with epilepsy and other seizure disorders, with the stated objective of improving prediction accuracy and enhancing patient safety through early warning systems. The firm's go-to-market model, pricing, customer segments, and revenue mechanics are not disclosed in the available source material; the company is described as a start-up with a headcount range of 11–50 employees, indicating a small, pre-commercial or early-commercial operating footprint typical of a Class II/III medical device developer navigating regulatory pathways.

The broader market context — global AI-driven seizure prediction wearables projected to reach $3.87 billion by 2030 — positions Brain Sentinel within a high-growth addressable market in which it is identified as one of the key companies. However, the input data carries material operational uncertainty: the company's registered domain, brainsentinel.com, is no longer under apparent company control and currently hosts an unrelated Indonesian-language online gambling blog ("BLOG WAKWAW") with content dated August 2025. No funding rounds, partnerships, regulatory clearances, named customers, management team, product launch dates, or certification milestones are disclosed in the input data, which limits the depth of any forward-looking assessment.

Short descriptiontext

Brain Sentinel is a privately held San Antonio–based medical device start-up, founded in 2011, that develops AI-driven wearable technology for convulsive seizure detection and prediction in patients with epilepsy and related seizure disorders.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Antonio, United States
HQ citystring
San Antonio
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
seizure detection devices, wearable medical devices, epilepsy monitoring systems, neurological diagnostic devices, AI seizure prediction
Industry2 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAJ
Neurology RPM (epilepsy, Parkinson’s, MS monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
Product category
Neurological Medical Devices
No data
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Brain Sentinel is a medical device company that develops and sells a convulsive seizure detection device built on AI-driven wearable technology. The device is intended for patients with epilepsy or seizure disorders and functions as an early warning system to improve seizure prediction accuracy and patient safety.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Convulsive Seizure Detection Device
CategoryWearable Neurological Medical Devices
Description

An AI-driven wearable medical device that detects convulsive seizures and provides early warning alerts to patients with epilepsy or seizure disorders and their caregivers, intended to improve patient safety through timely notification of seizure events outside clinical settings.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

NeuroPace markets the RNS System, a closed-loop neurostimulation device for refractory epilepsy. It is a direct peer serving the same neurology patient base through implanted and wearable neurotechnology for seizure management.

TypeEmerging player
Description

Byteflies builds wearable EEG and biosensor platforms focused on neurology and sleep, including epilepsy monitoring pilots. It is an emerging player with partial overlap in wearable neuro-monitoring technology.

TypeBroad incumbent
Description

Natus Medical is a long-established provider of neurodiagnostic and neurology devices, including EEG equipment used in seizure detection and monitoring. It is a broad incumbent with overlapping end markets in hospital and ambulatory neurology.

TypeEmerging player
Description

Epitel develops wearable EEG sensors and a cloud platform for continuous seizure monitoring in ambulatory settings. It is an emerging peer pursuing a similar AI-enabled ambulatory seizure-detection approach.

TypeDirect peer
Description

Empatica develops the Embrace wearable, an FDA-cleared smartwatch for detecting generalized tonic-clonic seizures. It is the closest direct competitor to Brain Sentinel, targeting the same epilepsy patient population with AI-driven wearable seizure detection.

TypeBroad incumbent
Description

Medtronic operates a large neurosciences portfolio including DBS and intracranial diagnostics. It competes indirectly with Brain Sentinel in the broader neurological-device space and represents a formidable incumbent for any seizure-monitoring entrant.

TypeBroad incumbent
Description

LivaNova is an established neuromodulation company whose VNS Therapy system is widely used for drug-resistant epilepsy. It is a broad incumbent competing in the same clinical indication with overlapping patient-safety value propositions.

TypeBroad incumbent
Description

Cadwell manufactures neurodiagnostic equipment including EEG systems used in epilepsy evaluation. It is a broad incumbent serving many of the same neurology clinical customers that Brain Sentinel's wearable device would target.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brain Sentinel

Neurological Medical Devicesbrainsentinel.com

Brain Sentinel is a privately held San Antonio–based medical device start-up, founded in 2011, that develops AI-driven wearable technology for convulsive seizure detection and prediction in patients with epilepsy and related seizure disorders.

What Brain Sentinel does

Brain Sentinel is a privately held, early-stage medical device company founded in 2011 and headquartered in San Antonio, Texas. The company develops AI-driven wearable technology aimed at detecting and predicting convulsive seizures in patients with epilepsy and other seizure disorders, with the stated objective of improving prediction accuracy and enhancing patient safety through early warning systems. The firm's go-to-market model, pricing, customer segments, and revenue mechanics are not disclosed in the available source material; the company is described as a start-up with a headcount range of 11–50 employees, indicating a small, pre-commercial or early-commercial operating footprint typical of a Class II/III medical device developer navigating regulatory pathways.

The broader market context — global AI-driven seizure prediction wearables projected to reach $3.87 billion by 2030 — positions Brain Sentinel within a high-growth addressable market in which it is identified as one of the key companies. However, the input data carries material operational uncertainty: the company's registered domain, brainsentinel.com, is no longer under apparent company control and currently hosts an unrelated Indonesian-language online gambling blog ("BLOG WAKWAW") with content dated August 2025. No funding rounds, partnerships, regulatory clearances, named customers, management team, product launch dates, or certification milestones are disclosed in the input data, which limits the depth of any forward-looking assessment.

Brain Sentinel firmographics

Firmographics
Name
Brain Sentinel
Website
https://brainsentinel.com
Company type
Private
Founded year
2011
Headcount range
1–10 employees
Short description
Brain Sentinel is a privately held San Antonio–based medical device start-up, founded in 2011, that develops AI-driven wearable technology for convulsive seizure detection and prediction in patients with epilepsy and related seizure disorders.
Ownership category
akta.pro rank

Brain Sentinel industry classification

Industry
Product category
Neurological Medical Devices
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAJ
Neurology RPM (epilepsy, Parkinson’s, MS monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Seizure detection devices
  • Wearable medical devices
  • Epilepsy monitoring systems
  • Neurological diagnostic devices
  • AI seizure prediction

Where Brain Sentinel is headquartered

Location

Headquarters

HQ city
San Antonio
HQ country
United States
HQ region
North America

Markets served

Brain Sentinel business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Brain Sentinel product offering

Product offering

Core offering

Brain Sentinel is a medical device company that develops and sells a convulsive seizure detection device built on AI-driven wearable technology. The device is intended for patients with epilepsy or seizure disorders and functions as an early warning system to improve seizure prediction accuracy and patient safety.

Differentiator

Problem solved

Functional benefit

Products and services

  • Convulsive Seizure Detection Device An AI-driven wearable medical device that detects convulsive seizures and provides early warning alerts to patients with epilepsy or seizure disorders and their caregivers, intended to improve patient safety through timely notification of seizure events outside clinical settings.

Companies that use Brain Sentinel

Customer profile

Ideal customer profiles1 record

Brain Sentinel technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Brain Sentinel partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Brain Sentinel competitors and assessment

Company assessment

Direct peers

  • NeuroPace: NeuroPace markets the RNS System, a closed-loop neurostimulation device for refractory epilepsy. It is a direct peer serving the same neurology patient base through implanted and wearable neurotechnology for seizure management.
  • Empatica: Empatica develops the Embrace wearable, an FDA-cleared smartwatch for detecting generalized tonic-clonic seizures. It is the closest direct competitor to Brain Sentinel, targeting the same epilepsy patient population with AI-driven wearable seizure detection.

Emerging players

  • Byteflies: Byteflies builds wearable EEG and biosensor platforms focused on neurology and sleep, including epilepsy monitoring pilots. It is an emerging player with partial overlap in wearable neuro-monitoring technology.
  • Epitel: Epitel develops wearable EEG sensors and a cloud platform for continuous seizure monitoring in ambulatory settings. It is an emerging peer pursuing a similar AI-enabled ambulatory seizure-detection approach.

Broad incumbents

  • Natus Medical: Natus Medical is a long-established provider of neurodiagnostic and neurology devices, including EEG equipment used in seizure detection and monitoring. It is a broad incumbent with overlapping end markets in hospital and ambulatory neurology.
  • Medtronic: Medtronic operates a large neurosciences portfolio including DBS and intracranial diagnostics. It competes indirectly with Brain Sentinel in the broader neurological-device space and represents a formidable incumbent for any seizure-monitoring entrant.
  • LivaNova: LivaNova is an established neuromodulation company whose VNS Therapy system is widely used for drug-resistant epilepsy. It is a broad incumbent competing in the same clinical indication with overlapping patient-safety value propositions.
  • Cadwell Industries: Cadwell manufactures neurodiagnostic equipment including EEG systems used in epilepsy evaluation. It is a broad incumbent serving many of the same neurology clinical customers that Brain Sentinel's wearable device would target.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights3 records

Customer concentration

Brain Sentinel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brain Sentinel leadership team

Management profile

Number of profiles

Brain Sentinel funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brain Sentinel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brain Sentinel

What does Brain Sentinel do?

Brain Sentinel is a medical device company that develops and sells a convulsive seizure detection device built on AI-driven wearable technology. The device is intended for patients with epilepsy or seizure disorders and functions as an early warning system to improve seizure prediction accuracy and patient safety.

When was Brain Sentinel founded?

Brain Sentinel was founded in 2011. It employs 1 to 10 people.

Where is Brain Sentinel based?

Brain Sentinel is headquartered in San Antonio, United States, in the North America region.

Who are Brain Sentinel's main competitors?

Direct peers on record are NeuroPace and Empatica. Emerging players are Byteflies and Epitel. Broad incumbents are Natus Medical, Medtronic, LivaNova and Cadwell Industries.

Does Brain Sentinel have an API?

No public API is recorded for Brain Sentinel.

What industry is Brain Sentinel in?

Brain Sentinel's product category is Neurological Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAFAJ, Neurology RPM (epilepsy, Parkinson’s, MS monitoring).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals